Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease

Clinical Hemorheology and Microcirculation

Volumn 41, Issue 2, 2009, Pages 137-142

  Pusl, Thomas ^a   Broedl, Uli C ^a   Parhofer, Klaus G ^a   Otto, Carsten ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Blood viscosity; Fibrinogen; Lipid; Red cell aggregation

Indexed keywords

FIBRINOGEN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOGRAPHY; APHERESIS; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ERYTHROCYTE AGGREGATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PLASMA VISCOSITY; BLOOD; CLINICAL TRIAL; LONGITUDINAL STUDY; METHODOLOGY; PILOT STUDY; PLASMAPHERESIS;

BLOOD VISCOSITY; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; ERYTHROCYTE AGGREGATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LONGITUDINAL STUDIES; MALE; PILOT PROJECTS; PLASMAPHERESIS;

EID: 66549097002     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1166     Document Type: Article

References (29)

1. B. Angelkort, B. Amann and H. Lawall, Hemorheology and hemostasis in vascular disease. A pathophysiological review, Clin. Hemorheol. Microcirc. 26 (2002), 145-154.
2. I. Tzoulaki, G.D. Murray, A.J. Lee et al., Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study, Circulation 115 (2007), 2119-2127.
3. A.J. Lee, P.I. Mowbray, G.D. Lowe et al., blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study, Circulation 97 (1998), 1467-1473.
4. G.D. Lowe, blood rheology in arterial disease, Clin. Sci. (London) 71 (1986), 137-146.
5. F.G. Fowkes, J.P. Pell, P.T. Donnan et al., Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity, Arterioscler. Thromb. 14 (1994), 862-868.
6. G.D. Lowe, blood viscosity and cardiovascular disease, Thromb. Haemost. 67 (1992), 494-498.
7. Y. Tsuda, K. Satoh, M. Kitadai et al., Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia, Atherosclerosis 122 (1996), 225-233.
8. S. Banyai, M. Banyai, J. Falger et al., Atorvastatin improves bood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment, Atherosclerosis 159 (2001), 513-519.
9. C. Otto, H.C. Geiss, E. Laubach et al., Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease, Ther. Apher. 6 (2002), 130-135.
10. T. Bosch, T. Wendler, B.R. Jaeger et al., Improvement of hemorheology by DALI apheresis: acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients, Ther. Apher. 5 (2001), 372-376.
11. P. Schuff-Werner, E. Schutz, W.C. Seyde et al., Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP), Eur. J. Clin. Invest. 19 (1989), 30-37.
12. P.M. Moriarty, C.A. Gibson, K.R. Kensey et al., Effect of low-density lipoprotein cholesterol apheresis on blood viscosity, Am. J. Cardiol. 93 (2004), 1044-1046.
13. C. Otto, H.C. Geiss, K. Empen et al., Long-term reduction of C-reactive protein concentration by regular LDL apheresis, Atherosclerosis 174 (2004), 151-156.
14. E. Ernst, C. Monshausen and A. Matrai, blood viscosity - A comparative study on three rotational instruments, Biorheology 22 (1985), 471-475.
15. E. Schmid-Schönbein, E. Volger, P. Teitel et al., New hemorheological techniques for the routine laboratory, Clin. Hemorheol. 2 (1983), 93-105.
16. R.M. Bauersachs, R.B. Wenby and H.J. Meiselman, Determination of specific red blood cell aggregation indices via an automated system, Clin. Hemorheol. 9 (1989), 1-25.
17. L.J. Drager, U. Julius, K. Kraenzle et al., DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results, Eur. J. Clin. Invest. 28 (1998), 994-1002.
18. W.O. Richter, M.G. Donner and P. Schwandt, Short- and long-term effects on serum lipoproteins by three different techniques of apheresis, Artif. Organs 20 (1996), 311-317.
19. H. Mabuchi, T. Higashikata and M.A. Kawashiri, Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia, Transfus. Apher. Sci. 30 (2004), 233-243.
20. N. Koga, The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia, Ther. Apher. 1 (1997), 260-270.
21. H. Mabuchi, J. Koizumi, M. Shimizu et al., Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group, Am. J. Cardiol. 82 (1998), 1489-1495.
22. J. Thiery and D. Seidel, Safety and effectiveness of long-term LDL-apheresis in patients at high risk, Curr. Opin. Lipidol. 9 (1998), 521-526.
23. E. Wieland, V. Schettler and V.W. Armstrong, Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis, Atherosclerosis 162 (2002), 187-191.
24. K. Empen, C. Otto, U.C. Brodl et al., The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1, J. Clin. Apher. 17 (2002), 38-43.
25. V. Schettler and E. Wieland, Effects of LDL-apheresis - more than reduction of cholesterol?, Dtsch. Med. Wochenschr. 132 (2007), 575-578.
26. P. Grutzmacher, H. Landgraf, R. Esser et al., In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation, ASAIO Trans. 36 (1990), 327-330.
27. C. Otto, M.M. Ritter, W.O. Richter et al., Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks, Metabolism 50 (2001), 166-170.
28. R. Ben-Ami, G. Barshtein, T. Mardi et al., A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation, Am. J. Physiol. Heart Circ. Physiol. 285 (2003), 2663H-2669H
29. W.H. Reinhart and C. Nagy, Albumin affects erythrocyte aggregation and sedimentation, Eur. J. Clin. Invest. 25 (1995), 523-528.